3 completed, 2 recruiting, 2 unknown, 1 active not recruiting. 10 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 3, Recruiting 2, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Translational Drug Development: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MTX-531-001 Phase 1 Study in Advanced Solid Tumors MTX-531 - Solid Tumors (Phase 1), HNSCC | Phase 1 | Not yet recruiting | MEKanistic Therapeutics, Inc. | 71 | 2026-10-20 | 2026-10-15 |
| Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors QN-302 - Solid Tumor | Phase 1 | Recruiting | Qualigen Theraputics, Inc. | 54 | 2023-11-01 | 2024-05-01 |
| Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors Decoy20, Tislelizumab - Solid Tumor, Adult, HCC - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Active not recruiting | Indaptus Therapeutics, Inc | 120 | 2023-02-28 | 2026-01-13 |
| Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy STP705 - Hepatocellular Carcinoma, Liver Metastases | Phase 1 | Completed | Sirnaomics | 5 | 2021-03-01 | 2024-03-19 |
| PK and Dose Escalation and Expansion Study of DST-2970 Abiraterone Acetate, Prednisone 5Mg Tab, DST-2970 (Abiraterone) - Prostate Cancer | Phase 1 | Terminated | DisperSol Technologies, LLC | 26 | 2020-01-31 | 2024-10-17 |
| Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer GZ17-6.02, Capecitabine - Advanced Cancer, Gastric Cancer | Phase 1 | Unknown | Genzada Pharmaceuticals USA, Inc. | 127 | 2019-03-01 | 2022-12-23 |
| A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine misetionamide (also known as GP-2250) - Ovarian Cancer | Phase 1 | Recruiting | Persevere Therapeutics Inc. | 18 | 2019-01-14 | 2026-10-19 |
| Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies NP-G2-044 - Breast Cancer, Pancreas Cancer | Phase 1 | Completed | Novita Pharmaceuticals, Inc. | 23 | 2017-12-21 | 2025-07-20 |
| A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors Minnelide™Capsules - Advanced Cancer, Gastric Cancer | Phase 1 | Unknown | Minneamrita Therapeutics LLC | 66 | 2017-10-10 | 2023-10-18 |
| A Pilot Study of Dociparstat Sodium (ODSH) in Acute Myeloid Leukemia Dociparstat sodium - Acute Myeloid Leukemia | Phase 1 | Completed | Jazz Pharmaceuticals | 12 | 2013-12-01 | 2023-02-21 |
Breast Neoplasms (3) · Colonic Neoplasms (3) · Pancreatic Neoplasms (3) · Carcinoma, Hepatocellular (2) · Colorectal Neoplasms (2) · Ovarian Neoplasms (2) · Prostatic Neoplasms (2) · Squamous Cell Carcinoma of Head and Neck (2) · Stomach Neoplasms (2) · Carcinoma, Basal Cell (1) · Carcinoma, Non-Small-Cell Lung (1) · Cholangiocarcinoma (1) · Endometrial Neoplasms (1) · Esophageal Neoplasms (1) · Leukemia, Myeloid, Acute (1)
Abiraterone Acetate (1) · Capecitabine (1) · Gemcitabine (1) · Injections (1) · N-desulfated,2-O,3-O-desulfated heparin (1) · NP-G2-044 (1) · Prednisone (1) · abiraterone (1) · tislelizumab (1)
United States (9)
Francois Lebel, MD (1) · Jillian Zhang, Ph.D. (1) · Jordan Jacobs, MBA (1) · Kathryn Gazarik (1) · Tariq Arshad, MD (1)